Historically, there has been a lack of cost-effectiveness data regarding the inclusion of universal non-invasive prenatal testing (NIPT) for trisomy 21, 18, and 13 in the benefit package of the Univer
In the simulations where the initial prevalence was 5.6. The prevalence cutoff is the level of within-herd prevalence that the farmer tolerates in a control scenario.
